Tedizolid phosphate
- Generic Name
- Tedizolid phosphate
- Brand Names
- Sivextro
- Drug Type
- Small Molecule
- Chemical Formula
- C17H16FN6O6P
- CAS Number
- 856867-55-5
- Unique Ingredient Identifier
- O7DRJ6R4DW
Overview
Drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and penicillin-resistant Streptococcus penumoniae, represent a massive public health threat. Tedizolid is a member of the oxazolidinone class of antibiotics, which includes the previously approved linezolid and is generally effective against multidrug-resistant Gram-positive bacteria. Tedizolid is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and is generally more effective and more tolerable than linezolid. Tedizolid was approved by the FDA on June 20, 2014, for sale by Cubist Pharmaceuticals as tedizolid phosphate (SIVEXTRO®). This product is currently available as both an oral tablet and as a powder for intravenous injection.
Background
Drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and penicillin-resistant Streptococcus penumoniae, represent a massive public health threat. Tedizolid is a member of the oxazolidinone class of antibiotics, which includes the previously approved linezolid and is generally effective against multidrug-resistant Gram-positive bacteria. Tedizolid is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and is generally more effective and more tolerable than linezolid. Tedizolid was approved by the FDA on June 20, 2014, for sale by Cubist Pharmaceuticals as tedizolid phosphate (SIVEXTRO®). This product is currently available as both an oral tablet and as a powder for intravenous injection.
Indication
Tedizolid is indicated for the treatment of acute bacterial infections of the skin and skin structure (ABSSSI). To prevent drug resistance, tedizolid should only be used for infections that are caused by susceptible bacteria.
Associated Conditions
- Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
Singapore Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. | Online |
|---|
No Singapore products found
No Singapore products found for this drug
China Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
Tedizolid Phosphate Tablets | 国药准字H20234209 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2023/09/28 | Domestic | |
Tedizolid Phosphate Tables | 国药准字H20234566 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2023/11/28 | Domestic | |
Tedizolid Phosphate Tablets | 国药准字H20223933 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2022/12/30 | Domestic | |
Tedizolid Phosphate Tablet | 国药准字H20244338 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2024/06/28 | Domestic | |
Tedizolid Phosphate Tablets | 国药准字H20243454 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2024/04/07 | Domestic | |
Tedizolid Phosphate Tablets | 国药准字H20234508 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2023/11/21 | Domestic | |
Tedizolid Phosphate Tablets | 国药准字H20249604 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2024/12/01 | Domestic | |
Tedizolid Phosphate Tablets | 国药准字H20223959 | 片剂 | N/A | 200mg | Chemical Drug | Approved | 2022/12/30 | Domestic | |
Tedizolid Phosphate Tablets | H20190029 | 片剂 | 赛威乐 | 200mg | Chemical Drug | Expired | 2019/06/13 | Import | |
Tedizolid Phosphate Tablets | 国药准字H20243435 | 片剂 | N/A | 0.2g | Chemical Drug | Approved | 2024/04/07 | Domestic |
Australia Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No Australia products found
No Australia products found for this drug